aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Select Market

2:38pm EDT
Change (% chg)

$1.23 (+5.12%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for LIFE.OQ


aTyr Pharma, Inc. is a clinical-stage biotherapeutics company. The Company is engaged in the discovery and clinical development of medicines for patients suffering from severe, rare diseases using a set of physiological modulators. The Company has discovered approximately 300 Physiocrines, a class of naturally occurring proteins... (more)
No analyst recommendations are available for LIFE.OQ.


Beta: --
Market Cap(Mil.): $541.19
Shares Outstanding(Mil.): 22.55
Dividend: --
Yield (%): --


  LIFE.OQ Industry Sector
P/E (TTM): -- 314.28 39.09
EPS (TTM): -1.10 -- --
ROI: -- -5.33 15.55
ROE: -- -6.26 16.55
Search Stocks

Thermo Fisher Q4 results top expectations on Life Tech buy

Jan 29 - Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, reported better-than-expected quarterly profit and sales, boosted by the contribution from the Life Technologies acquisition.

29 Jan 2015

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: S&P Capital IQ – STARS Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks